TRIAZOLOPYRIDINYL ETHER-LINKED COMPOUNDS AS KINASE INHIBITORS
ID202605951APending Publication Date: 2026-07-17BRISTOL MYERS SQUIBB CO
Patent Information
- Authority / Receiving Office
- ID · ID
- Patent Type
- Applications
- Current Assignee / Owner
- BRISTOL MYERS SQUIBB CO
- Filing Date
- 2024-09-26
- Publication Date
- 2026-07-17
Abstract
Compounds having the formula (I), and enantiomers, and diastereomers, stereoisomers, and their pharmaceutically acceptable salts, is useful as a kinase modulator, which includes modulation of RIPK1. All variables are as defined here.
Need to check novelty before this filing date? Find Prior Art